Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "IDS"

380 News Found

Gut microbiome as a tool in regenerative medicine
Biotech | May 07, 2022

Gut microbiome as a tool in regenerative medicine

Novel approach driven by GN Corp Japan with potentials in neurological illnesses


Fujifilm India installs Endobronchial Ultrasound System (EBUS) at ESIC Hospital, Faridabad
Hospitals | May 06, 2022

Fujifilm India installs Endobronchial Ultrasound System (EBUS) at ESIC Hospital, Faridabad

The EBUS is designed to support the diagnosis and staging of various lung disorders


Promising new universal coronavirus vaccine candidate discovered
News | May 05, 2022

Promising new universal coronavirus vaccine candidate discovered

Formula attenuates 99% of 365 coronaviruses in computer models


Fear of fourth wave drives Indians to search Covid health services
News | May 05, 2022

Fear of fourth wave drives Indians to search Covid health services

Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%


Physicians foresee an Alzheimer's Disease treatment revolution supported by advanced testing tools
Biotech | May 02, 2022

Physicians foresee an Alzheimer's Disease treatment revolution supported by advanced testing tools

Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education


USFDA approves Rinvoq as an oral treatment for ankylosing spondylitis
Drug Approval | May 01, 2022

USFDA approves Rinvoq as an oral treatment for ankylosing spondylitis

The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases


SPARSH Hospital introduces high precision Surgical Imaging and Navigation system
Hospitals | April 27, 2022

SPARSH Hospital introduces high precision Surgical Imaging and Navigation system

The StealthStation S8 and O-arm Surgical Navigation solution make a complex surgery seem more routine and free of any errors


Corbevax gets DCGI nod for Emergency Use in 5-12 years
Drug Approval | April 26, 2022

Corbevax gets DCGI nod for Emergency Use in 5-12 years

The approval comes soon after Corbevax was given the nod for 12-15-year group


ZyCoV-D two-dose vaccine receives Emergency Use Approval from DCGI
Drug Approval | April 26, 2022

ZyCoV-D two-dose vaccine receives Emergency Use Approval from DCGI

The two-dose regimen for ZyCoV-D was tested in 3100 healthy volunteers more than 12 years of age


Porton Advanced and Sinorda Biomedicine collaborate for cell therapy development for solid tumours
Biotech | April 25, 2022

Porton Advanced and Sinorda Biomedicine collaborate for cell therapy development for solid tumours

Under the agreement, Porton Advanced will provide services to accelerate the development, production and registration of breakthrough cell therapies currently being developed by Sinorda Biomedicine